A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma - NCT00744991-02115 (Clinical Trial 240175)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy240175.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Boston |
|
State:
|
|
MA |
| Zip Code: |
|
02115 |
| Conditions: |
|
Cutaneous T-Cell Lymphoma |
| Purpose: |
|
The purpose of the study is to determine the efficacy and safety of enzastaurin in patients
with CTCL who failed prior therapies.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Histologically confirmed mycosis fungoides or Sezary Syndrome
- Stage IB to IVB disease at screening
- Recurrent or refractory disease after at least 1 prior systemic therapy
- Have adequate organ function defined as:
- At least 30 days must have passed since other treatment for CTCL.
Exclusion Criteria:
- Receiving concurrent treatment for CTCL
- Unable to swallow tablets
- Receiving high potency oral or topical steroids. Low potency oral steroid may be
permitted in patients who have been on a stable dose for at least 4 weeks prior to
screening. Oral or topical antihistamine is allowed.
- Unable to discontinue use of carbamazepine, phenobarbital, or phenytoin
- Have a serious concomitant systemic disorder or HIV
- Have a serious cardiac condition such as myocardial infarction within past 6 months,
angina, or heart disease as defined by the New York Heart Association (NYHA) Class
III or IV
- Have ECG abnormalities,
- Are pregnant or breastfeeding |
|
|
|
| Study is available at: |
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Boston, MA 02115
United States
Primary Contact:
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Phone: 1-317-615-4559 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 16, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|